Evidence map›Paper›PMID 19505854›Full record

ArticleDNA repair2009

Tyrosyl-DNA phosphodiesterase and the repair of 3'-phosphoglycolate-terminated DNA double-strand breaks.

Tong Zhou, Konstantin Akopiants, Susovan Mohapatra, Peck-Sun Lin, Kristoffer Valerie, Dale A Ramsden, Susan P Lees-Miller, Lawrence F Povirk

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Role of TDP2 in the repair of DNA damage induced by the radiomimetic drug Bleomycin.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Tong ZhouDepartment of Pharmacology and Toxicology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Konstantin Akopiants
Susovan Mohapatra
Peck-Sun Lin
Kristoffer Valerie
Dale A Ramsden
Susan P Lees-Miller
Lawrence F Povirk
Virginia Commonwealth University · USUniversity of Calgary · CAUniversity of North Carolina at Chapel Hill · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Repair of DNA double-strand breaks with damaged endsR01CA040615 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVIRK, LAWRENCE F · 1985 to 2014
$3.2M
Tyrosyl-DNA phosphodiesterase and oxidative DNA damageR01AG023783 · NIA · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVIRK, LAWRENCE F · 2004 to 2008
$1.3M
NCI NIH HHS CA40615NCI NIH HHS P30 CA016059NCI NIH HHS P30 CA16059NCI NIH HHS R01 CA040615NIA NIH HHS AG023783NIA NIH HHS R01 AG023783
6 · The paper itself

Abstract

Although tyrosyl-DNA phosphodiesterase (TDP1) is capable of removing blocked 3' termini from DNA double-strand break ends, it is uncertain whether this activity plays a role in double-strand break repair. To address this question, affinity-tagged TDP1 was overexpressed in human cells and purified, and its interactions with end joining proteins were assessed. Ku and DNA-PKcs inhibited TDP1-mediated processing of 3'-phosphoglycolate double-strand break termini, and in the absence of ATP, ends sequestered by Ku plus DNA-PKcs were completely refractory to TDP1. Addition of ATP restored TDP1-mediated end processing, presumably due to DNA-PK-catalyzed phosphorylation. Mutations in the 2609-2647 Ser/Thr phosphorylation cluster of DNA-PKcs only modestly affected such processing, suggesting that phosphorylation at other sites was important for rendering DNA ends accessible to TDP1. In human nuclear extracts, about 30% of PG termini were removed within a few hours despite very high concentrations of Ku and DNA-PKcs. Most such removal was blocked by the DNA-PK inhibitor KU-57788, but approximately 5% of PG termini were removed in the first few minutes of incubation even in extracts preincubated with inhibitor. The results suggest that despite an apparent lack of specific recruitment of TDP1 by DNA-PK, TDP1 can gain access to and can process blocked 3' termini of double-strand breaks before ends are fully sequestered by DNA-PK, as well as at a later stage after DNA-PK autophosphorylation. Following cell treatment with calicheamicin, which specifically induces double-strand breaks with protruding 3'-PG termini, TDP1-mutant SCAN1 (spinocerebellar ataxia with axonal neuropathy) cells exhibited a much higher incidence of dicentric chromosomes, as well as higher incidence of chromosome breaks and micronuclei, than normal cells. This chromosomal hypersensitivity, as well as a small but reproducible enhancement of calicheamicin cytotoxicity following siRNA-mediated TDP1 knockdown, suggests a role for TDP1 in repair of 3'-PG double-strand breaks in vivo.

Indexed as

DNA Breaks, Double-StrandedDNA RepairAdenosine TriphosphateAminoglycosidesAntigens, NuclearCell DeathCell ExtractsChromosomes, HumanDNADNA-Activated Protein KinaseDNA-Binding ProteinsGene Knockdown TechniquesGlycolatesHeLa CellsHumansKu AutoantigenAdenosine TriphosphateAminoglycosidesAntigens, NuclearCell ExtractsDNADNA-Activated Protein KinaseDNA-Binding ProteinsGlycolatesKu AutoantigenMutant ProteinsNuclear ProteinsphosphoglycolatePhosphoric Diester HydrolasesPRKDC protein, humanProtein Kinase InhibitorsRecombinant ProteinsRNA, Small InterferingTDP1 protein, humanXrcc6 protein, human

Identifiers

PMID19505854
PMCPMC2763370
OpenAlexW2001330742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.